Nosocomial bacteriuria in elderly inpatients may be leading to considerable antibiotic overuse: an audit of current management practice in a secondary level care hospital in New Zealand by Blakiston M & Zaman S
© 2014 Blakiston and Zaman. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0)   
License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further 
permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on 
how to request permission may be found at: http://www.dovepress.com/permissions.php
Infection and Drug Resistance 2014:7 301–308
Infection and Drug Resistance Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
301
ORIgInal ReseaRch
open access to scientific and medical research
Open access Full Text article
http://dx.doi.org/10.2147/IDR.S66036
nosocomial bacteriuria in elderly inpatients may 
be leading to considerable antibiotic overuse: 
an audit of current management practice in a 
secondary level care hospital in new Zealand
Matthew Blakiston
syed Zaman
Department of Medicine, Midcentral 
District health Board, Palmerston 
north, new Zealand
correspondence: Matthew Blakiston 
email matt.blakiston@gmail.com
Background: Bacteriuria in the form of symptomatic urinary tract infection (UTI) and 
asymptomatic bacteriuria (ASB) is common in the elderly. There is no clinical benefit obtained 
by treating elderly individuals with ASB. However, its high prevalence leads to the overdiag-
nosis of UTI and unnecessary antibiotic use, which can result in adverse events, including 
Clostridium difficile diarrhea and reinfection with antibiotic-resistant organisms.
Methods: This was a retrospective audit that assessed the management of nosocomial bacte-
riuria in elderly patients admitted to the over-65 years rehabilitation unit of a secondary level 
care hospital in New Zealand. Identified bacteriuria episodes had the timing of sample collec-
tion relative to admission, microbial etiology, antibiotic susceptibility profile, inflammatory 
marker level, and treatment determined. Episodes were classified into six different clinical 
groups based on the presence or absence of signs and symptoms, urinary catheter status, and 
systemic inflammatory response. The proportion of bacteriuria episodes by clinical group-
ing and the level of treatment by clinical group were determined, followed by assessment of 
the amount of overtreatment in terms of the number of unnecessary antibiotic courses and 
unnecessary antibiotic treatment days.
Results: Significant bacteriuria was identified in 30% of patients, with 35% of urine samples 
collected in the immediate postadmission period. Fifty-four percent of the bacteriuria episodes 
were ASB or catheter-associated ASB (CA-ASB) without an inflammatory response, 24% were 
ASB or CA-ASB with raised inflammatory markers, and 22% were UTI or CA-UTI. The most 
common cause of bacteriuria was Escherichia coli, although the etiology was diverse, especially 
after prolonged hospitalization or in catheterized patients. A large proportion of organisms were 
resistant to one or more of the commonly used oral antibiotics. Treatment of ASB and CA-ASB 
accounted for 43% of all antibiotic courses received. Furthermore, treatment of ASB and CA-
ASB combined with unnecessarily prolonged treatment days for clinically relevant infections 
accounted for 55% of all antibiotic treatment days received.
Conclusion: The results suggest that inappropriate urine screening was occurring and that 
43% of antibiotic courses and 55% of all antibiotic treatment days were unnecessary. Current 
practice is amenable to improvement by performing urine culture only when clinically indicated, 
focusing on clinical signs and symptoms to diagnose clinically significant UTI rather than a 
positive culture, and using, where possible, the ecologically least damaging antibiotic for the 
shortest duration required.
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Introduction
Urinary tract infection (UTI) is a common infection in 
the elderly and accounts for substantial antibiotic use.1,2 
  Bacteriuria is the presence of bacteria in the urine and can be 
divided clinically into symptomatic UTI and asymptomatic 
bacteriuria (ASB) depending on the presence or absence of 
symptoms referable to the urinary tract.3,4
In the community setting, ASB is present in 15%–20% 
of females over the age of 70 years, and in 5%–10% of 
males over the age of 65 years, rising to 25%–50% and 
25%–40%, respectively, in aged residential care facilities.5 
The high prevalence of ASB in the elderly occurs in asso-
ciation with hypoestrogenic urogenital mucosal changes in 
postmenopausal women and varying degrees of prostatic 
hypertrophy-related urinary obstruction in older men.5 The 
risk of bacteriuria is also increased by age-related comor-
bidities such as cognitive impairment, incontinence, neu-
rological disease, diabetes, and indwelling urinary catheter 
use.1,5 Individuals with short-term urinary catheters have a 
3%–8% risk of bacteriuria each day the catheter is in place, 
and long-term urinary catheterization results in a prevalence 
of bacteriuria close to 100%.6 Escherichia coli is the leading 
cause of bacteriuria in the elderly.7 However, in comparison 
with the younger population, bacteriuria in the elderly is more 
frequently caused by other Enterobacteriaceae, Pseudomonas 
aeruginosa, or Enterococcus spp.7
The elderly population should not be screened or treated for 
ASB, as treatment does not affect the risk of symptomatic UTI, 
change chronic urinary symptoms, or alter overall survival.4,5 
The exception to the rule is in individuals undergoing invasive 
urological procedures.4 Unnecessary screening and treatment 
of ASB promotes reinfection with antibiotic-resistant organ-
isms and adverse drug events, including Clostridium difficile 
diarrhea, and generates avoidable laboratory and treatment 
costs.3–5 In hospitalized elderly patients, overdiagnosis of UTI 
is common.8 The identification of bacteriuria frequently trig-
gers antibiotic treatment regardless of signs or symptoms and 
perhaps even clinical assessment.2,9 Treatment of bacteriuria 
is also prompted by nonspecific changes in the elderly, such 
as functional decline or lethargy, without clear evidence for 
an association.1,3 Furthermore, malodorous urine and pyuria 
may incorrectly prompt urine culture and antibiotic treatment, 
respectively.4,5 It is recognized, however, that it can be chal-
lenging to differentiate ASB from UTI in the elderly, as they 
may lack classical urinary tract symptoms and have restricted 
communication.1,3 In the absence of other inflammatory con-
ditions, measuring blood inflammatory markers may assist 
management decisions regarding bacteriuria.3,10
In young women, the treatment of uncomplicated lower 
UTI with a short course (3 days) of antibiotics is well 
established.11 Conversely, in elderly women, uncompli-
cated lower UTI has traditionally been treated for 7 days 
or more. However, the available evidence and international 
guidelines now suggest that short course antibiotic therapy 
is also likely to be sufficient in elderly women, although the 
guidelines make recommendations only regarding therapy in 
the community.12,13 Complicated lower UTI, which includes 
UTI in males and those with catheters, and upper UTI 
should be treated for a minimum of 7 days.6,11,12 In catheter-
associated UTI (CA-UTI), the catheter should be changed 
or, if possible, removed to accelerate the speed of symptom 
resolution.6 Allowing for microbial susceptibility and the site 
of infection, antibiotics with the lowest impact on microbial 
ecology should be used.11 At the time of the audit, the local 
hospital guidelines that covered empiric antibiotic therapy 
recommended quinolones for nonseptic UTI and gentamicin 
plus amoxicillin for urosepsis.
Optimization of treatment practices in the elderly is 
required. The aim of this audit was to assess the management 
of bacteriuria in elderly inpatients, in comparison with pub-
lished guidelines, and to identify areas for improvement.
Methods
This was a retrospective audit of all significant bacteriuria 
episodes in patients admitted to the over-65 rehabilitation 
ward of a secondary level care hospital in New Zealand 
between July 1, 2011 and June 25, 2012. The over-65 reha-
bilitation unit receives medically stable patients from the 
acute medical and surgical services who require optimiza-
tion of their functional status before returning home or to 
residential care.
The electronic laboratory results of all patients admitted 
during the audit time period were reviewed to identify epi-
sodes of significant bacteriuria, causative organism(s), drug 
susceptibility results, and neutrophil and C-reactive protein 
levels. The threshold for significant bacteriuria was defined as 
$1×103 colony forming units/milliliter (CFU/mL) if a single 
organism was isolated, or $1×105 CFU/mL for mixed growth. 
A threshold of $1×103 CFU/mL was used for single organism 
isolates to maximize the capture of bacteriuria cases that may 
prompt treatment. When multiple urine cultures were taken 
from the same patient within 3 days of each other, they were 
considered to be the same episode, and only the first sig-
nificant bacteriuria result was included. The clinical records 
of individuals with significant bacteriuria were reviewed to 
identify any signs and symptoms,   indwelling urinary catheter Infection and Drug Resistance 2014:7 submit your manuscript | www.dovepress.com
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status, antimicrobial treatment, and total length of hospital-
ization. Bacteriuria episodes with available clinical records 
were then divided into clinical groups based on the presence 
or absence of signs and symptoms and urinary tract catheter-
ization, with asymptomatic episodes further subdivided based 
on the presence or absence of raised inflammatory markers 
(RIM) (Table 1). Fever and flank pain or tenderness was 
considered an indicator of potential upper UTI.
Treatment analysis was performed if clinical records were 
available, if the patient was not on antibiotics for another infec-
tion, and if the patient was still in hospital when bacteriuria 
was identified. Treatment of ASB and CA-ASB without an 
inflammatory marker rise was considered unwarranted. Unnec-
essarily prolonged treatment for clinically significant infections 
was also determined. A 3-day antibiotic course was used as the 
standard for uncomplicated lower UTI in females, except when 
nitrofurantoin was used, where 5 days was accepted. A 7-day 
course was used as the standard for lower UTI in males and 
CA infection. Extended antibiotic courses were accepted as 
prescribed in cases of upper UTI or urosepsis.
Data were collated and analyzed using SPSS software 
(IBM Corporation, Armonk, NY, USA) to generate descrip-
tive statistics and were graphically presented using   Microsoft 
Excel (Microsoft Corporation, Redmond, WA, USA). 
  Percentage values were rounded to the nearest whole number. 
This audit was conducted for the purpose of local   quality 
assurance in accordance with the National Health and 
  Disability Ethics Committee guidelines.14
Results
During the 12-month time period, 396 individuals were 
admitted to the over-65 rehabilitation unit, with 166 episodes 
of significant bacteriuria identified from 120 individuals. This 
equated to significant bacteriuria being identified in 30% of 
admissions. One hundred and sixty-two out of 166 bacteriu-
ria episodes had $1×105 CFU/mL. Of the 166 bacteriuria 
episodes, 109 (66%) were in female patients and 110 (66%) 
were in patients aged $80 years. The urine sample was col-
lected within 24 hours of admission in 35% of cases.
Admission records were available for 161 of the 166 
episodes. Of these 161 episodes, there were 53 cases of 
ASB (33%), 18 cases of ASB-RIM (11%), 26 cases of UTI 
(16%), 34 cases of CA-ASB (21%), 20 cases of CA-ASB-
RIM (12%), and ten cases of CA-UTI (6%) (Figure 1). 
Asymptomatic infection (ASB and CA-ASB) accounted 
for a larger proportion of the bacteriuria episodes in females 
(62%) compared with males (38%). Ten febrile bacteriuria 
episodes were potential upper UTIs, four of which had sys-
temic derangements suggesting urosepsis.
The most commonly identified organism(s) was 
E. coli (55, 33%), followed by “mixed growth” (47, 28%), 
P . aeruginosa (16, 10%), Klebsiella pneumoniae (15, 9%),   
Proteus mirabilis (12, 7%), Enterococcus spp. (9, 5%), 
Citrobacter spp. (3, 2%), Staphylococcus aureus (3, 2%), 
Enterobacter spp. (2, 1%), Morganella morganii (2, 1%), 
and non- S. saprophyticus coagulase-negative Staphylo-
coccus (2, 1%). Episodes reported as mixed growth were 
not further identified to the species level. The etiology of 
bacteriuria changed with catheter use, duration of hospital-
ization, and in symptomatic versus asymptomatic infection 
(Tables 2 and 3).
One hundred and fifty-six of the 166 bacteriuria episodes 
were eligible for analysis of treatment. Eighty-eight of the 
156 eligible bacteriuria episodes (56%) were treated with 
antibiotics. The proportion that received antimicrobial 
treatment was highest for UTI (89%), followed by CA-UTI 
(80%), ASB-RIM (59%), CA-ASB-RIM (50%), CA-ASB 
(46%), and ASB (44%) (Figure 2). In absolute terms, anti-
biotics were given for 23 episodes of ASB, 23 episodes 
of UTI, 15 episodes of CA-ASB, ten episodes of ASB-
RIM, nine episodes of CA-ASB-RIM, and eight episodes 
of CA-UTI (Figure 3). This meant that of all antibiotic 
courses given, 43% were for ASB and CA-ASB, 35% were 
Table 1 clinical grouping of bacteriuria episodes
asymptomatic  
bacteriuria (asB)
Noncatheter-associated significant bacteriuria 
with no locala or systemicb signs or symptoms 
and no inflammatory marker elevation
asB with raised  
inflammatory markers  
(asB-RIM)
Noncatheter-associated significant bacteriuria 
with no local or systemic signs or symptoms 
but with raised inflammatory markersc
Urinary tract infection  
(UTI)
Noncatheter-associated significant bacteriuria 
with one or more local or systemic signs or 
symptoms not attributable to another cause
catheter-associated  
asymptomatic  
bacteriuria (ca-asB)
catheter-associatedd significant bacteriuria 
with no local or systemic signs or symptoms 
and no inflammatory marker elevation
ca-asB with raised  
inflammatory markers  
(ca-asB-RIM)
Catheter-associated significant bacteriuria 
with no local or systemic signs or symptoms 
but with raised inflammatory markers
catheter-associated  
urinary tract infection  
(ca-UTI)
Catheter-associated significant bacteriuria 
with one or more local or systemic signs or 
symptoms not attributable to another cause
Notes:  alocal signs and symptoms included as relevant were dysuria, frequency, 
hematuria, suprapubic pain or tenderness, and flank pain or tenderness; bsystemic 
signs and symptoms included as relevant were fever $37.5°c, acute confusion, 
and  urosepsis  syndrome  (urosepsis  syndrome  was  defined  as  two  or  more  of: 
T° $38.0°c, heart rate .90 per minute, respiratory rate .20 per minute, white cell 
count .12×109 cells/L, plus significant bacteriuria, and no other infectious source); 
ca neutrophil count of $7.5×109 cells/l or a c-reactive protein level of $30 mg/l 
was considered elevated; dcatheter-associated infection includes individuals who had 
a urinary catheter removed within the previous 48 hours.Infection and Drug Resistance 2014:7 submit your manuscript | www.dovepress.com
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for UTI and CA-UTI, and 22% were for ASB-RIM and 
CA-ASB-RIM.
Antibiotics were given by the oral route in 95% of treated 
episodes, with quinolones the most frequently used class 
(57%). There was a high prevalence of antibiotic resistance, 
particularly in association with catheterization and prolonged 
admission (Table 4). In 67% of treated episodes, antibiotics 
were started 24 hours or more after the sample was collected. 
In these cases, antibiotic selection is presumed to be largely 
based on susceptibility results, with the organisms sensi-
tive to the respective prescribed antibiotic in 96% of cases. 
In 33% of treated episodes, antibiotics were started on the 
same day as the sample was collected. In these cases, it is 
presumed that treatment was empiric, with the subsequently 
identified organism sensitive to the prescribed antibiotic in 
67% of cases.
All bacteriuria cases identified over the audit time 
period received a combined total of 553 antibiotic treat-
ment days. Appropriate length treatment of UTI and CA-
UTI accounted for 156 of 553 antibiotic treatment days 
(28%), and appropriate length treatment of ASB-RIM 
and CA-ASB-RIM accounted for 90 of 553 antibiotic 
treatment days (16%). Conversely, unnecessary treatment 
of ASB and CA-ASB accounted for 228 of 553 antibiotic 
treatment days (41%), and unnecessarily prolonged treat-
ment days for lower UTI, CA lower UTI, ASB-RIM, and 
CA-ASB-RIM accounted for 79 of 553 antibiotic treatment 
days (14%) (Figure 4).
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Figure 1 Number of bacteriuria episodes by clinical classification.
Abbreviations: ASB, asymptomatic bacteriuria; ASB-RIM, ASB with raised inflammatory markers; CA-ASB, catheter-associated ASB; CA-ASB-RIM, CA-ASB with raised 
inflammatory markers; CA-UTI, catheter-associated UTI; UTI, urinary tract infection.
Table 2 Microbial etiology of bacteriuria: overall, by IDc status, and by length of hospitalization
Organism(s) Frequency of isolation, n (%)
Overall Non-CA 
bacteriuriaa
CA  
bacteriuriaa
#2 weeks of  
hospitalization
2–4 weeks of 
hospitalization
.4 weeks of 
hospitalization
Escherichia coli 55 (33) 39 (40) 12 (19) 21 (58) 16 (26) 18 (26)
Mixed growth 47 (28) 28 (29) 18 (28) 10 (28) 17 (28) 20 (29)
Pseudomonas aeruginosa 16 (10) 7 (7) 9 (14) 3 (8) 7 (11) 6 (9)
Klebsiella pneumoniae 15 (9) 10 (10) 5 (8) 0 (0) 6 (10) 9f (13)
Proteus mirabilis 12 (7) 3 (3) 9 (14) 1 (3) 6 (10) 5 (7)
Enterococcus spp.b 9 (5) 4 (4) 5 (8) 0 (0) 1 (2) 8 (12)
Citrobacter spp.c 3 (2) 1 (1) 2 (3) 0 (0) 2 (3) 1 (1)
Staphylococcus aureus 3 (2) 2 (2) 1 (2) 1 (3) 2 (3) 0 (0)
Enterobacter spp.d 2 (1) 0 (0) 2 (3) 0 (0) 0 (0) 2 (3)
Morganella morganii 2 (1) 2 (2) 0 (0) 0 (0) 2 (3) 0 (0)
cnse 2 (1) 1 (1) 1 (2) 0 (0) 2 (3) 0 (0)
Total 166 97 64 36 61 69
Notes: aOnly 161 bacteriuria episodes were assessed for the presence of an IDC, as clinical notes were not available for five episodes; bEnterococci were not identified 
to species level; ctwo Citrobacter freundii and one C. koseri were identified; done Enterobacter cloacae and one E. aerogenes were identified; enovobiocin-sensitive cns (“not 
S. saprophyticus”) were not further identified; fincluding three extended-spectrum β-lactamase-producing strains. Percentages rounded to nearest whole number.
Abbreviations: CA, catheter associated; CNS, coagulase-negative Staphylococcus; IDC, indwelling urinary catheter; n, number of isolates of respective organism(s);   
%, percentage of bacteriuria episodes in respective group due to respective organism(s).Infection and Drug Resistance 2014:7 submit your manuscript | www.dovepress.com
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Figure 2 Level of antibiotic treatment of bacteriuria by clinical classification.
Abbreviations: ASB, asymptomatic bacteriuria; ASB-RIM, ASB with raised inflammatory markers; CA-ASB, catheter-associated ASB; CA-ASB-RIM, CA-ASB with raised 
inflammatory markers; CA-UTI, catheter-associated UTI; UTI, urinary tract infection.
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Figure 3 Number of antibiotic-treated bacteriuria episodes by clinical classification.
Abbreviations: ASB, asymptomatic bacteriuria; ASB-RIM, ASB with raised inflammatory markers; CA-ASB, catheter-associated ASB; CA-ASB-RIM, CA-ASB with raised 
inflammatory markers; CA-UTI, catheter-associated UTI; n, number of respective bacteriuria episodes treated with antibiotics; UTI, urinary tract infection.
Table 3 Microbial etiology of bacteriuria: by clinical classificationa
Organism(s) Frequency of isolation, n (%)
ASB ASB-RIM UTI CA-ASB CA-ASB-RIM CA-UTI
Escherichia coli 23 (43) 7 (39) 9 (35) 5 (15) 4 (20) 3 (30)
Mixed growth 16 (30) 8 (44) 4 (15) 13 (38) 3 (15) 2 (20)
Pseudomonas aeruginosa 3 (6) 1 (6) 3 (12) 5 (15) 2 (10) 2 (20)
Klebsiella pneumoniae 7 (13) 0 (0) 3 (12) 1 (3) 4 (20) 0 (0)
Proteus mirabilis 1 (2) 2 (11) 0 (0) 7 (21) 2 (10) 0 (0)
Enterococcus spp.b 0 (0) 0 (0) 4 (15) 0 (0) 3 (15) 2 (20)
Citrobacter spp.c 1 (2) 0 (0) 0 (0) 1 (3) 0 (0) 1 (10)
Staphylococcus aureus 1 (2) 0 (0) 1 (4) 1 (3) 0 (0) 0 (0)
Enterobacter spp.d 0 (0) 0 (0) 0 (0) 0 (0) 2 (10) 0 (0)
Morganella morganii 1 (2) 0 (0) 1 (4) 0 (0) 0 (0) 0 (0)
cnse 0 (0) 0 (0) 1 (4) 1 (3) 0 (0) 0 (0)
Total 53 18 26 34 20 10
Notes: aOnly 161 bacteriuria episodes were grouped, as clinical notes were not available for five episodes; bEnterococci were not identified to species level; ctwo Citrobacter 
freundii and one C. koseri were identified; done Enterobacter cloacae and one E. aerogenes were identified; enovobiocin-sensitive cns (“not S. saprophyticus”) were not further 
identified. Percentages rounded to nearest whole number.
Abbreviations: ASB, asymptomatic bacteriuria; ASB-RIM, ASB with raised inflammatory markers; CA-ASB, catheter-associated ASB; CA-ASB-RIM, CA-ASB with raised 
inflammatory markers; CA-UTI, catheter-associated UTI; CNS, coagulase-negative Staphylococcus; n, number of isolates of respective organism(s); UTI, urinary tract infection; 
%, percentage of bacteriuria episodes in respective clinical group due to respective organism(s).Infection and Drug Resistance 2014:7 submit your manuscript | www.dovepress.com
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Discussion
This audit assessed the management of nosocomial bacte-
riuria in elderly inpatients to identify areas for improvement 
in practice. The high prevalence of bacteriuria identified, 
in particular asymptomatic infection, is consistent with 
that reported in community dwelling and institutionalized 
elderly.5 This high pretest probability of finding bacteriuria 
regardless of the clinical presentation illustrates the limita-
tions of using urine culture to diagnose clinically relevant 
UTI in hospitalized elderly individuals.3,5 However, despite 
its limitation for diagnosing UTI, urine culture is required 
to facilitate antibiotic susceptibility testing and appropriate 
antibiotic selection.3 This is particularly important in noso-
comial infections where there are high levels of microbial 
diversity and antimicrobial resistance. The requirement for 
culture and antibiotic susceptibility testing was illustrated 
by the one-third of empirically treated episodes that subse-
quently had organisms identified that were resistant to the 
empiric antibiotic.
The high proportion of urine samples collected in the 
immediate postadmission period suggests that “admission 
urine screening” was occurring. We also know that cloudy 
or malodorous urine incorrectly prompts urine culture.5 
Ward staff need to limit these incorrect screening practices 
and erroneous treatment prompts by culturing urine only 
when a UTI is suspected on appropriate clinical grounds. 
This requires greater awareness of the nature of ASB in the 
elderly. Educational interventions targeted at urine screening 
practices and ASB management can decrease the number of 
urine cultures performed.15
The most frequent cause of bacteriuria was E. coli. 
Mixed growth was also common, particularly in asymp-
tomatic infection. This likely reflects anterior urethral and 
periurethral contamination, associated with frequent inability 
to obtain midstream urine samples in hospitalized elderly 
patients, and the high proportion of catheter samples, which 
are prone to polymicrobial infection. The diversity of species 
increased in catheterized patients and those with a longer 
duration of hospitalization, reflecting the breakdown of 
normal physiological barriers, exposure to nosocomial patho-
gens, and increased likelihood of prior antibiotic exposure, 
and highlights the importance of broad-spectrum antibiotic 
coverage when empirically treating nosocomial urosepsis. 
The microbial differences by clinical group are not distinct 
enough to dictate empiric antibiotic choice or predict the 
clinical significance of an individual isolate.
The local treatment recommendation of quinolones for 
nonseptic UTI was reflected in the results. However, the 
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proportion of isolates that were quinolone resistant was 
still large, especially in the isolates obtained after 4 weeks 
of hospitalization. This was associated with the increased 
frequency of isolation of intrinsically resistant Enterococ-
cus spp. and multidrug-resistant K. pneumoniae during 
this time. Minimizing the selection of antibiotic-resistant 
organisms is required through prudent use of antibiotics for 
all indications.1 Additionally, when antibiotics are required 
for UTI, agents associated with a lesser effect on gut flora 
and a lower risk of reinfection with resistant organisms, such 
as nitrofurantoin or trimethoprim, should be used where 
possible.11 This could be promoted by treatment guidelines 
that differentiate between empiric and drug susceptibility 
directed antibiotic use.
The proportion of ASB (44%) and CA-ASB (46%) epi-
sodes that were unnecessarily treated is comparable with that 
found in other preintervention studies.15 ASB and CA-ASB 
were treated less frequently than symptomatic infections; 
however, because they were the most commonly identified 
clinical groups, they still accounted for 43% of all antibiotic 
courses. This suggests that 43% of all antibiotic courses 
for bacteriuria were unwarranted. The diagnosis of a clini-
cally relevant UTI should be based primarily on signs and 
symptoms, but in elderly individuals this can be difficult, 
with some degree of overtreatment probably unavoidable. 
  However, the current level of overtreatment of ASB and CA-
ASB can be decreased through quality improvement interven-
tions, including treatment algorithms and staff education to 
address the correct management of bacteriuria.15,16
The episodes of ASB-RIM/CA-ASB-RIM illustrate 
the limitation of the UTI versus ASB dichotomy in elderly 
patients who may have a clinically relevant infection without 
typical signs or symptoms.3 Inflammatory markers may assist 
in elucidating the significance of bacteriuria.3 However, the 
best management of these patients is uncertain, and they 
require a full evaluation before attributing the inflammatory 
response to the bacteriuria.
Antibiotic treatment of ASB and CA-ASB, combined with 
the days of unnecessarily prolonged treatment of lower UTI, 
CA lower UTI, ASB-RIM, and CA-ASB-RIM, meant that 55% 
of all antibiotic treatment days appeared to be   unwarranted. 
The majority stemmed from the treatment of ASB and CA-
ASB. However, an excessive duration of treatment, largely 
for lower UTI in women, accounted for an important propor-
tion of overuse. There is a lack of evidence to support either 
short or long course treatment for nosocomial UTI in elderly 
women. However, it would be sensible to minimize exposure 
if possible. Short course treatment in appropriate cases, with 
measures that ensure that antibiotics are stopped promptly, is 
needed to decrease antibiotic overuse.
There are methodological limitations with a retrospective 
audit, with the clinical information available determined by 
the quality of documentation, potentially leading to misclassi-
fication of cases. Additionally, a single author (MB) extracted 
the data, which is a potential source of bias.
Conclusion
Unnecessary antibiotic treatment of bacteriuria exposes 
patients to avoidable drug side effects, increases the risk of 
C. difficile diarrhea, increases the risk of reinfection with 
resistant organisms, and generates unnecessary treatment 
costs.3–5 This audit demonstrated that nosocomial bacteriuria 
in the elderly can lead to substantial antibiotic overuse, and 
illustrated three broad areas of clinical practice that can be 
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Figure 4 Breakdown of all antibiotic treatment days received for bacteriuria.
Note: aUnnecessarily prolonged treatment of lower UTI, ca lower UTI, asB-RIM, and ca-asB-RIM. a 3-day antibiotic course was used as the standard in females, except 
when nitrofurantoin was used, where 5 days was accepted. a 7-day course was used as the standard in males and ca infection.
Abbreviations: ASB, asymptomatic bacteriuria; ASB-RIM, ASB with raised inflammatory markers; CA-ASB, catheter-associated ASB; CA-ASB-RIM, CA-ASB with raised 
inflammatory markers; CA-UTI, catheter-associated UTI; n, number of antibiotic treatment days; UTI, urinary tract infection.Infection and Drug Resistance
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improved upon. If ASB is not identified in the first place, 
erroneous treatment cannot be prompted. Therefore, reducing 
inappropriate urine culture is important. Clinically relevant 
UTI in the elderly should be diagnosed primarily by signs 
and symptoms, not just by the presence of a positive culture. 
Improving the interpretation of ASB and CA-ASB results is 
required to reduce overtreatment. Lastly, management can 
be optimized in bacteriuria episodes requiring treatment by 
using the ecologically least damaging antibiotics for the 
shortest duration required.
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